Literature DB >> 12079781

Investigation of RNA-protein and RNA-metal ion interactions by electron paramagnetic resonance spectroscopy. The HIV TAR-Tat motif.

Thomas E Edwards1, Tamara M Okonogi, Snorri Th Sigurdsson.   

Abstract

Electron paramagnetic resonance (EPR) spectroscopy was used to investigate changes in dynamics of spin-labeled nucleotides in the TAR RNA (U23, U25, U38, and U40) upon binding to cations, argininamide, and two peptides derived from the Tat protein. Nearly identical changes in dynamics were obtained for either calcium or sodium ions, indicating the absence of a calcium-specific structural change for the TAR RNA in solution that had previously been suggested by crystallographic data. Similar dynamic signatures were obtained for two Tat-derived peptides that have the same important binding determinant (R52) and similar binding affinities to the TAR RNA. However, U23 and U38 were substantially less mobile for the wild-type peptide (YGRKKRRQRRR) than for the mutant (YKKKKRKKKKA), demonstrating that, flanking R52, amino acids in the wild-type sequence make specific contacts to the RNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079781     DOI: 10.1016/s1074-5521(02)00150-3

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  13 in total

1.  Probing Na(+)-induced changes in the HIV-1 TAR conformational dynamics using NMR residual dipolar couplings: new insights into the role of counterions and electrostatic interactions in adaptive recognition.

Authors:  Anette Casiano-Negroni; Xiaoyan Sun; Hashim M Al-Hashimi
Journal:  Biochemistry       Date:  2007-05-09       Impact factor: 3.162

Review 2.  Site-directed spin labeling studies on nucleic acid structure and dynamics.

Authors:  Glenna Z Sowa; Peter Z Qin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2008

Review 3.  RNA dynamics: perspectives from spin labels.

Authors:  Phuong Nguyen; Peter Z Qin
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-22       Impact factor: 9.957

4.  Exploring the Reaction Mechanism of HIV Reverse Transcriptase with a Nucleotide Substrate.

Authors:  Hao Wang; Nathan Huang; Tyler Dangerfield; Kenneth A Johnson; Jiali Gao; Ron Elber
Journal:  J Phys Chem B       Date:  2020-05-18       Impact factor: 2.991

5.  Shortening the HIV-1 TAR RNA Bulge by a Single Nucleotide Preserves Motional Modes over a Broad Range of Time Scales.

Authors:  Dawn K Merriman; Yi Xue; Shan Yang; Isaac J Kimsey; Anisha Shakya; Mary Clay; Hashim M Al-Hashimi
Journal:  Biochemistry       Date:  2016-08-04       Impact factor: 3.162

6.  Studying RNA using site-directed spin-labeling and continuous-wave electron paramagnetic resonance spectroscopy.

Authors:  Xiaojun Zhang; Pavol Cekan; Snorri Th Sigurdsson; Peter Z Qin
Journal:  Methods Enzymol       Date:  2009-11-17       Impact factor: 1.600

7.  Experimental mapping of DNA duplex shape enabled by global lineshape analyses of a nucleotide-independent nitroxide probe.

Authors:  Yuan Ding; Xiaojun Zhang; Kenneth W Tham; Peter Z Qin
Journal:  Nucleic Acids Res       Date:  2014-08-04       Impact factor: 16.971

8.  Argininamide binding arrests global motions in HIV-1 TAR RNA: comparison with Mg2+-induced conformational stabilization.

Authors:  Stephen W Pitt; Ananya Majumdar; Alexander Serganov; Dinshaw J Patel; Hashim M Al-Hashimi
Journal:  J Mol Biol       Date:  2004-04-16       Impact factor: 5.469

9.  The internal dynamics of mini c TAR DNA probed by electron paramagnetic resonance of nitroxide spin-labels at the lower stem, the loop, and the bulge.

Authors:  Yan Sun; Ziwei Zhang; Vladimir M Grigoryants; William K Myers; Fei Liu; Keith A Earle; Jack H Freed; Charles P Scholes
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

10.  Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.

Authors:  Greg L Olsen; Thomas E Edwards; Pritilekha Deka; Gabriele Varani; Snorri Th Sigurdsson; Gary P Drobny
Journal:  Nucleic Acids Res       Date:  2005-06-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.